# BORTEZOMIB
> **NDA212782** · New Drug Application · Sponsor: SHILPA · Approved 2024-08-26
## Drug
- **FDA Application Number:** NDA212782
- **Application type:** New Drug Application
- **Brand name:** BORTEZOMIB
- **Generic name:** BORTEZOMIB
- **Active ingredients:** BORTEZOMIB
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS, SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** SHILPA
- **Manufacturer:** Amneal Pharmaceuticals LLC
- **First approval:** 2024-08-26
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212782)
---
*AI Analytics · CC0 1.0*